⌘K

Login Start Free

Home/Filings/4/0001127602-22-026099

4//SEC Filing

Douglas Robert Andrew 4

Accession 0001127602-22-026099

CIK 0000943819other

View on SEC.gov Company Profile

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 8:08 PM ET

Size

6.4 KB

Accession

0001127602-22-026099

Insider Transaction Report

Form 4

Period: 2022-11-16

Douglas Robert Andrew

COO Asia Pacific

Transactions

Award
ResMed Common Stock Options
2022-11-16$224.58/sh+31,649$7,107,732→ 31,649 total
Exercise: $224.58From: 2023-11-11Exp: 2029-11-16→ ResMed Common Stock (31,649 underlying)

Holdings

ResMed Common Stock
40,186
ResMed Common Stock
(indirect: By Trust)
227,708

Footnotes (1)

[F1]Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2023, 2024 and 2025.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

RESMED INC

CIK 0000943819

Entity typeother

Related Parties

1

filerCIK 0001352232

Filing Metadata

Form type: 4
Filed: Nov 17, 7:00 PM ET
Accepted: Nov 18, 8:08 PM ET
Size: 6.4 KB

View on SEC.gov